Representative participants: NOW Foods, Life Extension Foundation, Thorne Research, Pure Encapsulations, and Source Naturals
Results Eleven patients had a history of gastrectomy and 11 did not
Semaglutide was approved for use in the United States in 2017 as a long-acting GLP-1 RA
Recently, an Ozempic class action lawsuit, with plaintiffs claiming that the drug caused severe health problems, is the latest legal action
Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up
Under the Medicare GLP-1 Bridge, eligible beneficiaries can get Medicare coverage of GLP-1s for obesity for a $50 monthly copayment, which will not count towards the Part D deductible or out-of-pocket spending cap and Part D Low-Income Subsidy cost-sharing assistance will not apply